Onconova Therapeutics, Inc. Reports Business Highlights and First Quarter 2019 Financial Results

    NEXT STORY
    resTORbio Appoints Lloyd Klickstein, M.D., Ph.D., as Chief Scientific Officer
    PREV STORY
    Myriad Genetics to Present Multiple Studies at the 2019 American Society of Clinical Oncology Annual Meeting
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Global In-Vitro Diagnostics Market Will Reach USD 87.3 Billion by 2024: Zion Market Research

    According to the report, global in-vitro diagnostics market was valued at around USD 62.0 ...

    author_avatar
    NASDAQ Market News

    Dynavax Presents Analysis of Data for Participants Aged 60 to 70 with Diabetes from its Phase 3 Trial of HEPLISAV-B®

    In a Post-Hoc Analysis of Elderly Diabetic Patients, HEPLISAV-B was Well-Tolerated and Induced Higher ...

    author_avatar
    NASDAQ Market News

    BioTelemetry, Inc. to Release Second Quarter 2016 Earnings Results on August 2, 2016

    MALVERN, Pa., July 26, 2016 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT) will release its ...

    author_avatar
    NASDAQ Market News